Clinical Utility of Circulating Tumor Cells for Predicting Major Histopathological Response after Neoadjuvant Chemoradiotherapy in Patients with Esophageal Cancer

Background: A “surgery as needed” approach may be offered to patients with esophageal cancer (EC) who achieve major histopathological response (MaHR) after neoadjuvant chemoradiotherapy (nCRT). However, the utility of clinical response assessment (CRE) for predicting histopathological response to nC...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xing, Leow, Osbert Qi-Yao, Chiu, Chien-Hung, Hou, Ming-Mo, Hsieh, Jason Chia-Hsun, Chao, Yin-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502866/
https://www.ncbi.nlm.nih.gov/pubmed/36143225
http://dx.doi.org/10.3390/jpm12091440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502866/
https://www.ncbi.nlm.nih.gov/pubmed/36143225
http://dx.doi.org/10.3390/jpm12091440

Ejemplares similares